References For "Did You Know?" Facts:
- More than 4,000,000 prescriptions for RESTASIS® have been written to date
- Data on file. Allergan, Inc.
- After using RESTASIS® for 2 months, 83% of patients planned to continue using RESTASIS® Ophthalmic Emulsion. (n=3,127 )
- Trattler W, Katsev D, Kerney D. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys. Clin Ther: 2007;28:1848-1856.
- Only 5 out of 293 patients in clinical trials discontinued RESTASIS® due to burning and stinging
- Sall K, Stevenson OD, Mundorf, Reis BL, and the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631-639.
- Chronic Dry Eye is the most common patient complaint in the ophthalmologist's office
- Stevenson D, Tauber J, Reis BL, and The Cyclosporin A Phase 2 Study Group. Efficacy and safety of Cyclosporin A Ophthalmic Emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. Ophthalmology. 2000;107:967-974.
- While estimates vary, at least 3.2 million women in the U.S. Suffer from Chronic Dry Eye
- Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:2318-2326.
